Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4221632 | Clinical Imaging | 2015 | 4 Pages |
Abstract
PurposeThe utility of the apparent diffusion coefficient (ADC) in patients with clear-cell renal cell carcinoma (RCC) for distinguishing between the four clinical stages was assessed.MethodsForty-nine patients with pathologically proven RCCs (I, II, III, IV; 27, 5, 10, 7) were included. The ADC was compared between each stage.ResultsThe difference of ADC between stage I and the more advanced stages (III and IV) was statistically significant.ConclusionsWhen ADC in primary tumor site of clear-cell RCC would be higher than the cutoff level, the stage might not be an advanced stage (III or IV).
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Tomonori Nakamura, Takeshi Yoshizako, Hisayoshi Araki, Mitsunari Maruyama, Koji Uchida, Yukihisa Tamaki, Noriyuki Ishikawa, Hiroaki Shiina, Hajime Kitagaki,